Takahashi M - Search Results

1

Disappearance of serum hepatitis C virus RNA within two days after one dose interferon administration is predictive for response to high-dose interferon-alpha 2b treatment for chronic hepatitis C. Keio Interferon-alpha 2b Study Group.

Saito H, Ebinuma H, Atsukawa K, Takahashi M, Masuda T, Ohishi T, Nojiri O, Mizuoka K, Ishii H. Saito H, et al. Among authors: takahashi m. Keio J Med. 1997 Jun;46(2):74-80. doi: 10.2302/kjm.46.74. Keio J Med. 1997. PMID: 9212590 Free article. Clinical Trial.

2

Reduced in vitro immunoglobulin secretion from peripheral blood mononuclear cells in responders to high-dose interferon-alpha 2b treatment for chronic hepatitis C.

Atsukawa K, Saito H, Ebinuma H, Morizane T, Takahashi M, Ohishi T, Kumagai N, Tsuchimoto K, Ishii H. Atsukawa K, et al. Among authors: takahashi m. Hepatogastroenterology. 2000 Nov-Dec;47(36):1685-90. Hepatogastroenterology. 2000. PMID: 11149032 Clinical Trial.

3

Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level.

Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Tsuji T, Shin S, Tanno M, Urdea MS, Kolberg JA. Yamada G, et al. Among authors: takahashi m. Hepatology. 1995 Nov;22(5):1351-4. Hepatology. 1995. PMID: 7590646

4

Treatment of chronic hepatitis C with interferon-alpha: sustained absence of hepatitis C virus RNA from serum after four courses of therapy.

Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Takahashi M. Toyoda H, et al. Among authors: takahashi m. J Int Med Res. 1995 Jul-Aug;23(4):308-14. doi: 10.1177/030006059502300412. J Int Med Res. 1995. PMID: 7589775

5

Quantitative hepatitis C virus RNA and liver histology in chronic hepatitis C patients treated with interferon alfa.

Yamada G, Takahashi M, Endo H, Doi T, Miyamoto R, Shimomura H, Yamamoto K, Tsuji T. Yamada G, et al. Among authors: takahashi m. Gut. 1993;34(2 Suppl):S133-4. doi: 10.1136/gut.34.2_suppl.s133. Gut. 1993. PMID: 8390954 Free PMC article.

6

Hepatitis C virus antibody titration in patients with chronic hepatitis C, before and after interferon treatment.

Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Nishimoto H, Fujiki S, Shimomura H, Mizuno M, Tsuji T. Takahashi M, et al. Acta Med Okayama. 1992 Oct;46(5):331-6. doi: 10.18926/AMO/32660. Acta Med Okayama. 1992. PMID: 1279945 Free article.

7

Biochemical markers and bone mineral density in patients with hip fractures in men.

Ohishi T, Takahashi M, Kushida K, Omura T. Ohishi T, et al. Among authors: takahashi m. Endocr Res. 2000 May;26(2):275-88. doi: 10.3109/07435800009066167. Endocr Res. 2000. PMID: 10921453

8

Evaluation of bone turnover in postmenopause, vertebral fracture, and hip fracture using biochemical markers for bone formation and resorption.

Takahashi M, Kushida K, Hoshino H, Ohishi T, Inoue T. Takahashi M, et al. J Endocrinol Invest. 1997 Mar;20(3):112-7. doi: 10.1007/BF03346887. J Endocrinol Invest. 1997. PMID: 9186815

9

Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis.

Takahashi M, Kushida K, Hoshino H, Miura M, Ohishi T, Inoue T. Takahashi M, et al. Clin Endocrinol (Oxf). 1997 Aug;47(2):177-83. doi: 10.1046/j.1365-2265.1997.2221055.x. Clin Endocrinol (Oxf). 1997. PMID: 9302392

10

Urinary collagen crosslinks reflect further bone loss of femoral neck in osteoporotic patients undergoing vitamin D therapy.

Ohishi T, Takahashi M, Kushida K, Yamazaki K, Hoshino H, Kitazawa A, Inoue T. Ohishi T, et al. Among authors: takahashi m. Endocr Res. 1998 May;24(2):259-67. doi: 10.1080/07435809809135533. Endocr Res. 1998. PMID: 9738702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,226 results

Search Page

Filters